Holen Sie sich die Stockscreener-App
8.37
6.90%
0.54
Handel nachbörslich:
8.37
Schlusskurs vom Vortag:
$7.83
Offen:
$8.61
24-Stunden-Volumen:
3,014
Relative Volume:
0.35
Marktkapitalisierung:
$12.86M
Einnahmen:
$630.00K
Nettoeinkommen (Verlust:
$5.72M
KGV:
-24.51
EPS:
-0.3415
Netto-Cashflow:
$-6.75M
1W Leistung:
-5.21%
1M Leistung:
+1.95%
6M Leistung:
+7.86%
1J Leistung:
+3.08%
1-Tages-Spanne:
$8.2151
$8.61
1-Wochen-Bereich:
$7.524
$8.71
52-Wochen-Spanne:
$6.51
$13.27
Addex Therapeutics Ltd Adr Stock (ADXN) Company Profile
Firmenname
Addex Therapeutics Ltd Adr
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie ADXN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ADXN
Addex Therapeutics Ltd Adr
|
8.37 | 8.37M | 630.00K | 5.72M | -6.75M | -0.3415 |
|
VRTX
Vertex Pharmaceuticals Inc
|
476.95 | 120.73B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.39 | 60.56B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.64 | 42.41B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
575.42 | 34.96B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
294.83 | 31.99B | 3.81B | -644.79M | -669.77M | -6.24 |
Addex Therapeutics Ltd Adr Stock (ADXN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-07-31 | Hochstufung | H.C. Wainwright | Neutral → Buy |
Addex Therapeutics Ltd Adr Aktie (ADXN) Neueste Nachrichten
Addex Therapeutics (NASDAQ:ADXN) Stock Price Down 4.5% – Here’s Why - Defense World
Addex Therapeutics Reports Q1 2025 Financial Results - TipRanks
Addex Therapeutics to Release Q1 2025 Financial Results and Host Conference Call on June 19, 2025 - GlobeNewswire Inc.
European Equities See Growth In US ADR Market - Finimize
Addex Raises $10.0 Million In Equity Financing - Barchart.com
Addex Therapeutics Earnings Call: Strategic Gains Amid Financial Challenges - TipRanks
Addex Therapeutics Reports Strong 2024 Financial Turnaround - TipRanks
META_TITLE_SECTORS - Yahoo Finance
Are Medical Stocks Lagging ADMA Biologics (ADMA) This Year? - Yahoo Finance
Are Medical Stocks Lagging Addex Therapeutics (ADXN) This Year? - Nasdaq
Akebia Therapeutics (AKBA) Reports Q3 Loss, Misses Revenue Estimates - Yahoo Finance
Are Medical Stocks Lagging Boston Scientific (BSX) This Year? - Yahoo Finance
Drug discovery and bringing new medicine to marketthe future of AI in pharma - OutSourcing-Pharma.com
What Makes Addex Therapeutics (ADXN) a New Buy Stock - Nasdaq
Is Boston Scientific (BSX) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
LYRA Stock Quote Price and Forecast - CNN
Esperion Therapeutics (ESPR) Reports Q3 Loss, Tops Revenue Estimates - Nasdaq
Addex Therapeutics (ADXN) Stock Rallied 62.1% on Phase 2 Study - AskTraders.com
Le 1001 azioni che si sono schiantate sul mercato azionario USA - Scenari Economici
Addex (ADXN) Terminates Parkinson's-Related Dyskinesia Study - Nasdaq
Addex To Present At The H.C. Wainwright BIOCONNECT Virtual Conference - Barchart.com
Addex Reports Q3 2021 Financial Results And Provides Corporate Update - Barchart.com
ADXN Stock Price and Chart — SIX:ADXN - TradingView
Finanzdaten der Addex Therapeutics Ltd Adr-Aktie (ADXN)
Umsatz
Nettogewinn
Free Cashflow
ENV
4.91%
0.25%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):